乳腺癌化学疗法诱导的神经病的电频率:一个随机对照试验
Qiongying Shen1, Dehou Deng2, Guangliang Li3
1The Third Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, China.
The oncologist
|August 19, 2025
概括
电针 (EA) 在乳腺癌患者的化疗诱导的周围神经病变 (CIPN) 中显示出有前途. 2/100Hz频率显示了最高的响应率,而2Hz EA改善了感官症状,这表明CIPN管理的个性化频率选择.
科学领域:
- 综合性瘤学是一种综合性瘤学.
- 神经学 神经学
- 癌症支持性护理 癌症支持性护理
背景情况:
- 化疗诱导的周围神经病变 (CIPN) 是乳腺癌治疗中常见的剂量限制副作用.
- 电针 (EA) 正在被探索为CIPN的潜在干预,但最佳刺激参数需要定义.
- 这项研究研究了不同EA频率在管理CIPN.的有效性.
研究的目的:
- 为了比较各种电针 (EA) 频率与甲胺的有效性,用于治疗乳腺癌患者的化疗诱导的周围神经病变 (CIPN).
- 确定最佳的EA刺激参数,以改善神经毒性症状和生活质量.
主要方法:
- 一个单中心,单盲随机试验比较了2Hz,100Hz和2/100Hz的EA,加上甲胺 (Mecbl).
- 主要结局:患者神经毒性问卷 (PNQ) 响应率在第4周.
- 二次结果:PNQ分数,NCI-CTCAE等级,EORTC QLQ-CIPN20和EORTC QLQ-C30等级在第4周和第8周.
主要成果:
- 2/100Hz EA组显示了最高的整体响应率.
- 2Hz和2/100HzEA都在第4周显著改善了PNQ感官得分.
- 2HzEA增强了身体功能,疲劳,疼痛和失眠,而2/100HzEA改善了胃肠道症状和整体健康.
- 100Hz EA在评估的领域没有显示出显著的好处.
结论:
- 这项探索性研究表明,不同的EA频率为CIPN产生了不同的治疗特征.
- 2/100Hz频率显示出最全面的效果,而2Hz EA对感官改善特别有效.
- 基于患者症状概况的个性化频率选择可以优化CIPN的EA治疗.
相关概念视频
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
259
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
259
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
321
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
321
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
440
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
440
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
366
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
366